Sign in
8-K

Current Report

Inhibitor Therapeutics, Inc. Filed Acc 0001193125-13-362750

Material agreement · Bylaws or fiscal year change · Regulation FD disclosure

  • Item 1.01 Entry into a material definitive agreement
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading d595990d8k.htm…